Phase 2 Randomized Data: A Multi-System Approach to Metabolic Health, Body Composition, & Muscle Function in Older Adults
9:00 am - Wednesday 9th December 2026
- A multi-active immunotherapy designed to address multi-system age-related decline across metabolic, muscular, and functional health
- Metabolic benefits observed in Phase 2a double-blind, randomized clinical trial include reversal of pre-diabetes, reduction of liver fat, and improvements in body composition
- Muscle and functional benefits include improved gait speed, muscle strength, quality of life, and physical activity, supporting a comprehensive approach to healthy aging
